Literature DB >> 21406060

Immunopathogenesis of severe asthma.

Christopher E Brightling1, Sumit Gupta, Fay Hollins, Amanda Sutcliffe, Yassine Amrani.   

Abstract

Severe asthma is a complex heterogeneous disease with substantial unmet clinical need. Understanding the immunopathogenesis is likely to provide insights into potential novel therapies. To date researchers have focussed primarily at a single scale for example genome, cell or whole organ physiology. In this review we shall summarise the current knowledge of the immunopathogenesis of severe asthma integrated across multiple scales to provide the insights into the structure function relationships required to begin to unravel the complexity of severe asthma.

Entities:  

Mesh:

Year:  2011        PMID: 21406060     DOI: 10.2174/138161211795429028

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  7 in total

1.  Effect of the plant derivative Compound A on the production of corticosteroid-resistant chemokines in airway smooth muscle cells.

Authors:  Adelina Gavrila; Latifa Chachi; Omar Tliba; Christopher Brightling; Yassine Amrani
Journal:  Am J Respir Cell Mol Biol       Date:  2015-11       Impact factor: 6.914

2.  Functional KCa3.1 channels regulate steroid insensitivity in bronchial smooth muscle cells.

Authors:  Peter Bradding; Yassine Amrani; Latifa Chachi; Aarti Shikotra; S Mark Duffy; Omar Tliba; Christopher Brightling
Journal:  J Immunol       Date:  2013-07-31       Impact factor: 5.422

3.  House dust allergy and immunotherapy.

Authors:  Wayne R Thomas
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

4.  Is there a regulatory role of immunoglobulins on tissue forming cells relevant in chronic inflammatory lung diseases?

Authors:  Michael Roth
Journal:  J Allergy (Cairo)       Date:  2011-11-02

Review 5.  Role of PGE2 in asthma and nonasthmatic eosinophilic bronchitis.

Authors:  Beatriz Sastre; Victoria del Pozo
Journal:  Mediators Inflamm       Date:  2012-03-19       Impact factor: 4.711

6.  Therapeutic Potential of Combining IL-6 and TNF Blockade in a Mouse Model of Allergic Asthma.

Authors:  Olga A Namakanova; Ekaterina A Gorshkova; Ruslan V Zvartsev; Sergei A Nedospasov; Marina S Drutskaya; Ekaterina O Gubernatorova
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

7.  Prevalence of IgE-mediated allergy and evaluation of Th1/Th2 cytokine profiles in patients with severe bronchial asthma.

Authors:  Barbara Rogala; Andrzej Bozek; Joanna Gluck; Jerzy Jarzab
Journal:  Postepy Dermatol Alergol       Date:  2015-08-12       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.